HighTide Therapeutics Inc (02511.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.4x

Market Cap

HKD 1.57B

MomentumView details →

1D Return

+0.00%

YTD Return

+4.41%

RSI (14)

47.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.4x

Market Cap

HKD 1.57B

RSI (14)

47.4

MomentumView details →

1D Return

+0.00%

YTD Return

+4.41%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−336.61%

ROA (TTM)

−148.54%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+64.66%

FCF YoY

+73.86%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+39.29%

EBITDA YoY

+60.34%

EarningsView details →

EPS (Actual)

−HKD 0.33

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.93x

Current Ratio

3.28x

Quick Ratio

3.28x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−562.07M

Op. CF (TTM)

—

Next earningsMar 26, 2027 →

Latest newsMore news →

Junshi Tai Medical (02511.HK) reported an interim loss of 146 million RMB for the six months ended June 2026, widening from 120 million RMB a year earlier, with no dividend declared.4d ago

Similar companies

RAPT Therapeutics, Inc.RAPT SinoMab BioScience Limited03681.HK Xeris Biopharma Holdings, Inc.XERS NewAmsterdam Pharma Company N.V.NAMSW Guangzhou Innogen Pharmaceutl Grp Co Ltd02591.HK LB Pharmaceuticals Inc Common StockLBRX Find similar companies →

Latest newsMore news →

Junshi Tai Medical (02511.HK) reported an interim loss of 146 million RMB for the six months ended June 2026, widening from 120 million RMB a year earlier, with no dividend declared.4d ago